Published Aug 08, 2018

Harbour BioMed inks $350 million deal for rights to A167

USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167

Related or similar articles

View more News

March 13, 2019

Labshares Celebrates Grand Opening and Unveils Newly Expanded Shared Office and Lab Space in Newton

Labshares Newton's newly expanded facility features a cutting-edge lab and co-working space that can now accommodate up to 30 startups

October 9, 2024

Explore Labshares' Latest High-Tech Equipment Advancements

November 2, 2018

Life Sciences Co-Working Incubator Labshares Launches in Newton

A new office and laboratory incubator for emerging biotechnology and life science companies has just opened in Newton’s Charles River Mill District.